Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biomarin Pharm Shares Downgraded by Zacks Investment Research to “Underperform” (BMRN)
Biomarin Pharm Shares Downgraded by Zacks Investment Research to “Underperform” (BMRN)
Biomarin Pharm Shares Downgraded by Zacks Investment Research to “Underperform” (BMRN)
Submitted by
admin
on February 11, 2012 - 12:52pm
Source:
Web Inquirer, UK
News Tags:
Biomarin
Headline:
Biomarin Pharm Shares Downgraded by Zacks Investment Research to “Underperform” (BMRN)
Do Not Allow Advertisers to Use My Personal information
